Patient-Reported Outcomes with Long-Acting Cabotegravir and Rilpivirine in People Living with HIV
Patient Preference and Adherence · 2026-08 · Volume 20 · 1-10
DOI: 10.2147/ppa.s607613 ↗Kurz gefasst
Fachartikel in der Zeitschrift Patient Preference and Adherence, 2026-08. Verfasst von Ana Codonal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Department, Santos Reyes Hospital, Aranda de Duero, Spain. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pharmacy Department, Santos Reyes Hospital, Aranda de Duero, Spain.
- University of Alcalá, Alcalá de Henares, Spain.
- Pharmacy Department, University Hospital of Guadalajara, Guadalajara, Spain.
- Internal Medicine Department, University Hospital of Guadalajara, Guadalajara, Spain.
- Health Research Institute of Castilla-La Mancha (IDISCAM), Toledo, Spain.
ORCID-Profile: Ana Codonal, Miguel Torralba
Zitieren
APA
Codonal, A., Lázaro, A., Martínez, E., Delgado, A., & Torralba, M. (2026). Patient-Reported Outcomes with Long-Acting Cabotegravir and Rilpivirine in People Living with HIV. Patient Preference and Adherence, Volume 20, 1-10. https://doi.org/10.2147/ppa.s607613
Vancouver
Codonal A, Lázaro A, Martínez E, Delgado A, Torralba M. Patient-Reported Outcomes with Long-Acting Cabotegravir and Rilpivirine in People Living with HIV. Patient Preference and Adherence. 2026;Volume 20:1-10. doi:10.2147/ppa.s607613
BibTeX
@article{Codonal2026,
author = {Codonal, Ana and Lázaro, Alicia and Martínez, Elena and Delgado, Alberto and Torralba, Miguel},
title = {Patient-Reported Outcomes with Long-Acting Cabotegravir and Rilpivirine in People Living with HIV},
journal = {Patient Preference and Adherence},
year = {2026},
volume = {Volume 20},
pages = {1--10},
doi = {10.2147/ppa.s607613}
}
EUVIMED